HCPCS code J1413 — Inj delandistrogene mox rokl. Status: Active. Effective Jan 1, 2024. Source: CMS HCPCS Level II.

J1413

Active

Inj delandistrogene mox rokl

Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jan 1, 2024
Code type: alphanumeric
OPPS Status: G — Pass-through drugs and biologicals
OPPS APC: 0714

MUE — Medically Unlikely Edits

Maximum units of J1413 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 1
Practitioner Services 1

Source: CMS Medicare NCCI Medically Unlikely Edits

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2024-Q1
    Inj delandistrogene mox rokl